The U.S. Food and Drug Administration (FDA) has recently given vaccine manufacturers Pfizer/BioNTech and Moderna an Emergency Use Authorization (EUA) to issue COVID-19 vaccines utilizing RNA (mRNA) technology. Legally speaking, this means the vaccines are still experimental and not licensed by the FDA, and the public already starting to suffer from the consequences of this decision.
In less than a week, between December 14 and December 18, the Centers for Disease Control and Prevention (CDC) already reported 3,150 cases of “Health Impact Events.” The definition of Health Impact Events, according to the CDC, is “unable to perform normal daily activities, unable to work, required care from doctor or health care professional.” However, the information trail ends here — the CDC didn’t specify anything about the “health impact events” these 3,150 people experienced.
Further highlighting the dangers of these experimental vaccines are six cases of anaphylaxis, also reported by the CDC. Anaphylaxis is a life-threatening allergic reaction that can cause symptoms such as skin redness, breathing troubles, abdominal or chest pain, irregular heartbeat, cardiac arrest and even death.
As more people continue to be vaccinated, more reports are coming out that these drugs can cause other health problems. In one trial, people who had dermal fillers six months before vaccination developed facial or lip swelling. In another experiment, there were four reported cases of Bell’s palsy, a disease that can cause symptoms such as facial paralysis, drooling, jaw pain and increased sensitivity to sound.
Despite the increasing number of people suffering from the side effects of the vaccines, what’s troubling is that the CDC still insists that vaccination must go on. Simply put, a history of anaphylaxis to prior vaccines or injectable therapies is just a precaution, not a contraindication. Furthermore, if a person develops a vaccine-related injury, the manufacturers are shielded from liability through the Public Readiness and Emergency Preparedness (PREP) Act.
Vaccine recipients who develop serious injuries or die may be compensated through the Countermeasures Injury Compensation Program (CICP) by the U.S. Department of Health and Human Services (HHS).
Sources:
The Vaccine Reaction, December 22, 2020
FDA, December 11, 2020
FDA, December 18, 2020